Giuseppe Mallel
Rehovot, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study.
Journal: JCO precision oncology
Published: October 11, 2024
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Journal: Frontiers in medicine
Published: May 12, 2023
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Journal: Nature communications
Published: January 10, 2023
TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
Journal: Molecular oncology
Published: August 26, 2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Journal: Nature communications
Published: January 12, 2022
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 05, 2021
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.
Journal: Nature communications
Published: May 26, 2021
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.
Journal: Nature cancer
Published: February 07, 2021
The human tumor microbiome is composed of tumor type-specific intracellular bacteria.
Journal: Science (New York, N.Y.)
Published: July 29, 2019
Adenomyoepithelioma of the breast: case report and literature review.
Journal: Il Giornale di chirurgia
Published: July 25, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026